KUEBLER CHRISTOPHER A 4
4 · WATERS CORP /DE/ · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Waters (WAT) Director Christopher Kuebler Receives Award
What Happened
- Christopher A. Kuebler, a director of Waters Corporation (WAT), was granted equity awards on Feb 25, 2026. The filing reports an award of 23 shares of common stock (restricted) and a derivative grant covering 57 shares (stock option-like), both reported at $0.00 and totaling 80 shares with $0 cash exchanged. These are awards (compensation), not open-market purchases or sales.
Key Details
- Transaction date: 2026-02-25; Form 4 filed 2026-02-27 (timely).
- Reported prices: $0.00 for both the 23-share award and the 57-share derivative grant; total reported value $0.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes:
- F1: The 23 shares are restricted and 100% of these restrictions lapse on Feb 9, 2027.
- F2: The 57-share derivative is a stock option; the underlying shares will vest and become exercisable on Feb 9, 2027.
- Filing status: Timely (filed within the Form 4 reporting window).
Context
- These are standard director compensation awards—restricted shares and an option-style grant that vest in about one year—rather than a market purchase or sale. Derivative grants (options) give the holder the right to acquire shares upon vesting/exercise; this filing does not indicate any immediate sale or exercise. As with most grants, the awards reflect compensation and should not alone be taken as a buy/sell signal.
Insider Transaction Report
Form 4
KUEBLER CHRISTOPHER A
Director
Transactions
- Award
Common Stock
[F1]2026-02-25+23→ 17,808 total - Award
Stock Option (Right to Buy)
[F2]2026-02-25+57→ 57 totalExercise: $319.44From: 2027-02-09Exp: 2036-02-25→ Common Stock (57 underlying)
Footnotes (2)
- [F1]Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.
- [F2]All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.
Signature
/s/ Michael Lynn, attorney-in-fact for Christopher A. Kuebler|2026-02-27